These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16585661)

  • 1. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.
    Rodondi N; Peng T; Karter AJ; Bauer DC; Vittinghoff E; Tang S; Pettitt D; Kerr EA; Selby JV
    Ann Intern Med; 2006 Apr; 144(7):475-84. PubMed ID: 16585661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study.
    Weiler S; Gemperli A; Collet TH; Bauer DC; Zimmerli L; Cornuz J; Battegay E; Gaspoz JM; Kerr EA; Aujesky D; Rodondi N
    BMC Health Serv Res; 2014 Jul; 14():306. PubMed ID: 25027581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment intensification and risk factor control: toward more clinically relevant quality measures.
    Selby JV; Uratsu CS; Fireman B; Schmittdiel JA; Peng T; Rodondi N; Karter AJ; Kerr EA
    Med Care; 2009 Apr; 47(4):395-402. PubMed ID: 19330888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
    Schmittdiel JA; Uratsu CS; Karter AJ; Heisler M; Subramanian U; Mangione CM; Selby JV
    J Gen Intern Med; 2008 May; 23(5):588-94. PubMed ID: 18317847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes.
    Schmittdiel JA; Traylor A; Uratsu CS; Mangione CM; Ferrara A; Subramanian U
    J Womens Health (Larchmt); 2009 Dec; 18(12):2065-70. PubMed ID: 20044871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recidivism to uncontrolled blood pressure in patients with previously controlled hypertension.
    Sandhu A; Ho PM; Asche S; Magid DJ; Margolis KL; Sperl-Hillen J; Rush B; Price DW; Ekstrom H; Tavel H; Godlevsky O; O'Connor PJ
    Am Heart J; 2015 Jun; 169(6):791-7. PubMed ID: 26027616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meaningful variation in performance: what does variation in quality tell us about improving quality?
    Selby JV; Schmittdiel JA; Lee J; Fung V; Thomas S; Smider N; Crosson FJ; Hsu J; Fireman B
    Med Care; 2010 Feb; 48(2):133-9. PubMed ID: 20057330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of diabetes care management in managed care.
    Schmittdiel JA; Uratsu CS; Fireman BH; Selby JV
    Am J Manag Care; 2009 May; 15(5):295-301. PubMed ID: 19435397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between medical treatment compliance and the degree of control in patients with high blood pressure, non-insulin dependent diabetes mellitus and dyslipidemia].
    Piñeiro F; Gil V; Donis M; Orozco D; Pastor R; Merino J
    Med Clin (Barc); 1998 Nov; 111(15):565-7. PubMed ID: 9859088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
    JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).
    Lyles CR; Karter AJ; Young BA; Spigner C; Grembowski D; Schillinger D; Adler N
    J Gen Intern Med; 2011 Oct; 26(10):1138-44. PubMed ID: 21547610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in diabetic patients with hypertension.
    Winer N; Sowers JR
    Curr Diab Rep; 2002 Jun; 2(3):263-6. PubMed ID: 12643183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.